Therefore, to observe the effects of DNA-PKcs inactivation specifically on EC pathology and microvascular injury during endotoxemia, we used the genetically modified mice for subsequent functional experiments. This evidence concerns the gene PRKDC and serum lipopolysaccharide activity.